Enhanced expression of bone morphogenetic protein system in aldosterone-treated mouse kidneys

Hypertension Research

Volumn 35, Issue 3, 2012, Pages 312-317

  Suzuki, Jiro ^a   Otsuka, Fumio ^a   Matsumoto, Yoshinori ^a   Inagaki, Kenichi ^a   Miyoshi, Tomoko ^a   Takeda, Masaya ^a   Tsukamoto, Naoko ^a   Nakamura, Eri ^a   Ogura, Kanako ^a   Makino, Hirofumi ^a  

^a OKAYAMA UNIVERSITY   (Japan)

Author keywords

aldosterone; bone morphogenetic protein (BMP); glomerulus; kidney; salt sensitive hypertension

Indexed keywords

ALDOSTERONE; BONE MORPHOGENETIC PROTEIN 4; MESSENGER RNA; MINERALOCORTICOID RECEPTOR; OSTEOGENIC PROTEIN 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BAGG ALBINO MOUSE; BLOOD PRESSURE; BODY WEIGHT; CELL PROLIFERATION; CONTROLLED STUDY; EXTRACELLULAR MATRIX; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; KIDNEY CORTEX; KIDNEY INJURY; KIDNEY MASS; MALE; MESANGIUM CELL; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEINURIA; SALT INTAKE;

ADMINISTRATION, ORAL; ALDOSTERONE; ANIMALS; BONE MORPHOGENETIC PROTEIN 4; BONE MORPHOGENETIC PROTEIN 7; CELL PROLIFERATION; EXTRACELLULAR MATRIX; INJECTIONS, INTRAPERITONEAL; KIDNEY CORTEX; KIDNEY GLOMERULUS; MALE; MESANGIAL CELLS; MICE; MICE, INBRED BALB C; MODELS, ANIMAL; RECEPTORS, MINERALOCORTICOID; RNA, MESSENGER; SODIUM CHLORIDE, DIETARY;

EID: 84857982783     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1038/hr.2011.186     Document Type: Article

References (28)

1. Rafiq K, Hitomi H, Nakano D, Nishiyama A. Pathophysiological roles of aldosterone and mineralocorticoid receptor in the kidney. J Pharmacol Sci 2011; 115: 1-7.
2. Nishiyama A, Hitomi H, Rahman A, Kiyomoto H. Drug discovery for overcoming chronic kidney disease (CKD): pharmacological effects of mineralocorticoid-receptor blockers. J Pharmacol Sci 2009; 109: 1-6.
3. Nishiyama A, Yao L, Nagai Y, Miyata K, Yoshizumi M, Kagami S, Kondo S, Kiyomoto H, Shokoji T, Kimura S, Kohno M, Abe Y. Possible contributions of reactive oxygen species and mitogen-activated protein kinase to renal injury in aldosterone/salt-induced hypertensive rats. Hypertension 2004; 43: 841-848. (Pubitemid 38405598)
4. Nishiyama A, Yao L, Fan Y, Kyaw M, Kataoka N, Hashimoto K, Nagai Y, Nakamura E, Yoshizumi M, Shokoji T, Kimura S, Kiyomoto H, Tsujioka K, Kohno M, Tamaki T, Kajiya F, Abe Y. Involvement of aldosterone and mineralocorticoid receptors in rat mesangial cell proliferation and deformability. Hypertension 2005; 45: 710-716. (Pubitemid 40418370)
5. Todd-Turla KM, Schnermann J, Fejes-Toth G, Naray-Fejes-Toth A, Smart A, Killen PD, Briggs JP. Distribution of mineralocorticoid and glucocorticoid receptor mRNA along the nephron. Am J Physiol 1993; 264: F781-F791. (Pubitemid 23149705)
6. Hostetter TH, Ibrahim HN. Aldosterone in chronic kidney and cardiac disease. J AmSoc Nephrol 2003; 14: 2395-2401. (Pubitemid 37052388)
7. Simic P, Vukicevic S. Bone morphogenetic proteins in development and homeostasis of kidney. Cytokine Growth Factor Rev 2005; 16: 299-308. (Pubitemid 40910319)
8. Wang SN, Lapage J, Hirschberg R. Loss of tubular bone morphogenetic protein-7 in diabetic nephropathy. J Am Soc Nephrol 2001; 12: 2392-2399. (Pubitemid 33021116)
9. Hruska KA, Guo G, Wozniak M, Martin D, Miller S, Liapis H, Loveday K, Klahr S, Sampath TK, Morrissey J. Osteogenic protein-1 prevents renal fibrogenesis associated with ureteral obstruction. Am J Physiol Renal Physiol 2000; 279: F130-F143. (Pubitemid 30619554)
10. Dudley AT, Lyons KM, Robertson EJ. A requirement for bone morphogenetic protein-7 during development of the mammalian kidney and eye. Genes Dev 1995; 9: 2795-2807.
11. Kitten AM, Kreisberg JI, Olson MS. Expression of osteogenic protein-1 mRNA in cultured kidney cells. J Cell Physiol 1999; 181: 410-415. (Pubitemid 29513409)
12. Morrissey J, Hruska K, Guo G, Wang S, Chen Q, Klahr S. Bone morphogenetic protein-7 improves renal fibrosis and accelerates the return of renal function. J Am Soc Nephrol 2002; 13(Suppl 1): S14-S21. (Pubitemid 34008173)
13. Wang S, Hirschberg R. BMP7 antagonizes TGF-beta-dependent fibrogenesis in mesangial cells. Am J Physiol Renal Physiol 2003; 284: F1006-F1013. (Pubitemid 36443585)
14. Dudley AT, Robertson EJ. Overlapping expression domains of bone morphogenetic protein family members potentially account for limited tissue defects in BMP7 deficient embryos. Dev Dyn 1997; 208: 349-362. (Pubitemid 27114288)
15. Otani H, Otsuka F, Inagaki K, Takeda M, Miyoshi T, Suzuki J, Mukai T, Ogura T, Makino H. Antagonistic effects of bone morphogenetic protein-4 and-7 on renal mesangial cell proliferation induced by aldosterone through MAPK activation. Am J Physiol Renal Physiol 2007; 292: F1513-F1525. (Pubitemid 46701879)
16. Otsuka F, Yamauchi T, Kataoka H, Mimura Y, Ogura T, Makino H. Effects of chronic inhibition of ACE and AT1 receptors on glomerular injury in dahl salt-sensitive rats. Am J Physiol 1998; 274: R1797-R1806.
17. Takeda M, Otsuka F, Suzuki J, Kishida M, Ogura T, Tamiya T, Makino H. Involvement of activin/BMP system in development of human pituitary gonadotropinomas and nonfunctioning adenomas. Biochem Biophys Res Commun 2003; 306: 812-818. (Pubitemid 36776203)
18. Uhrenholt TR, Schjerning J, Hansen PB, Norregaard R, Jensen BL, Sorensen GL, Skott O. Rapid inhibition of vasoconstriction in renal afferent arterioles by aldosterone. Circ Res 2003; 93: 1258-1266. (Pubitemid 37547959)
19. Brown NJ. Aldosterone and end-organ damage. Curr Opin Nephrol Hypertens 2005; 14: 235-241. (Pubitemid 40685635)
20. Martinez G, Bertram JF. Organisation of bone morphogenetic proteins in renal development. Nephron Exp Nephrol 2003; 93: e18-e22.
21. Vukicevic S, Kopp JB, Luyten FP, Sampath TK. Induction of nephrogenic mesenchyme by osteogenic protein 1 (bone morphogenetic protein 7). Proc Natl Acad Sci USA 1996; 93: 9021-9026. (Pubitemid 26282011)
22. Dudley AT, Godin RE, Robertson EJ. Interaction between FGF and BMP signaling pathways regulates development of metanephric mesenchyme. Genes Dev 1999; 13: 1601-1613. (Pubitemid 29297927)
23. Lechner MS, Dressler GR. The molecular basis of embryonic kidney development. Mech Dev 1997; 62: 105-120. (Pubitemid 27215781)
24. Raatikainen-Ahokas A, Hytonen M, Tenhunen A, Sainio K, Sariola H. BMP-4 affects the differentiation of metanephric mesenchyme and reveals an early anterior-posterior axis of the embryonic kidney. Dev Dyn 2000; 217: 146-158. (Pubitemid 30080494)
25. Wang S, Chen Q, Simon TC, Strebeck F, Chaudhary L, Morrissey J, Liapis H, Klahr S, Hruska KA. Bone morphogenic protein-7 (BMP-7), a novel therapy for diabetic nephropathy. Kidney Int 2003; 63: 2037-2049. (Pubitemid 36605815)
26. Kim S, Ohta K, Hamaguchi A, Omura T, Yukimura T, Miura K, Inada Y, Wada T, Ishimura Y, Chatani F. Role of angiotensin II in renal injury of deoxycorticosterone acetate-salt hypertensive rats. Hypertension 1994; 24: 195-204.
27. Juknevicius I, Segal Y, Kren S, Lee R, Hostetter TH. Effect of aldosterone on renal transforming growth factor-beta. Am J Physiol Renal Physiol 2004; 286: F1059-F1062. (Pubitemid 38656360)
28. Ueda H, Miyazaki Y, Matsusaka T, Utsunomiya Y, Kawamura T, Hosoya T, Ichikawa I. Bmp in podocytes is essential for normal glomerular capillary formation. J Am Soc Nephrol 2008; 19: 685-694.